Featured Content

More News

Sector News

More News

News and Analysis

  • Come Join Our Commuity We are offering discounted subscription plans to join BioMedReports.com for a limited time.
  • Q&A with LabStyle Innovations Exec VP, Todd Durniak Recently, LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, announced it had closed a round of funding totaling approximately $2.5 million. According to management, the monies will be used to support the global rollout and initial U.S. commercial launch of their flagship product Dario™ for working capital purposes.
More News


BioMedReports Blue Sphere Corp announced today the expansion of its operating team: https://t.co/GGwyn4Iyr8 $BLSP
BioMedReports Pluristem reported financial highlights for last year and provided clinical and corporate updates: https://t.co/qa0DKYolqJ $PSTI
BioMedReports TapImmune Tackles Ovarian Cancer in Fast Track Phase II Clinical Trials: https://t.co/lIuGN94R1k $TPIV

RSS Subscription